ライフサイエンスコーパス: inhibitory concentration

1 ombination with ciprofloxacin (2.5 x minimum inhibitory concentration).

2 by peptide concentrations below the minimal inhibitory concentration.

3 ll molecules and measured their half-maximal inhibitory concentration.

4 ylamide (TM(inh)-23) with 30 nM half-maximal inhibitory concentration.

5 well below the protein-binding-adjusted 90% inhibitory concentration.

6 cern the molecular mechanism and the minimum inhibitory concentration.

7 aluated by disk diffusion assays and minimum inhibitory concentration.

8 tro identified compounds with potent minimum inhibitory concentrations.

9 he half maximal (IC50) and the minimal (MIC) inhibitory concentrations.

10 types, as well as metadata including minimum inhibitory concentrations.

11 tained over a period of 7 days above minimal inhibitory concentrations.

12 ssess its effect on the antibiotics' minimum inhibitory concentrations.

13 obial compounds which it contains are at non-inhibitory concentrations.

14 valent to unencapsulated tobramycin (minimum inhibitory concentration 0.625mg/L).

15 n the MCL cell lines with lower half-maximal inhibitory concentration (0.1-0.5 muM), pevonedistat ind

16 DTG concentrations exceeded the in vitro 50% inhibitory concentration (0.21 ng/mL) by a median of 214

17 mL) and antiaflatoxigenic (minimum aflatoxin inhibitory concentration = 0.07 muL/mL) activities.

18 EO-Nm exhibited improved antifungal (minimum inhibitory concentration = 0.08 muL/mL) and antiaflatoxi

19 0.137 +/- 0.007 mM; LS vs. HS; half-maximal inhibitory concentration, 0.055 nM).

20 O4(-) uptake via hNIS in vitro (half-maximal inhibitory concentration, 0.55-0.56 muM (in comparison w

21 substrate-like NNMT inhibitors (half-maximal inhibitory concentration 1.41 muM).

22 und to GRPR with high affinity (half maximal inhibitory concentration, 1-2 nM).

23 ost promising properties (e.g., half-maximal inhibitory concentration, 19.2 +/- 5.8, tumor-to-muscle

24 nhibitory concentration (>= fT > 1 x minimum inhibitory concentration); 2) were above four times the

25 showed a selective inhibitory profile and an inhibitory concentration 50 (IC(50)) of <0.003 muM for b

26 The inhibitory concentration 50% (IC50) of NSC319726 was 35-

27 9726 was 35-800-fold higher than the Minimum Inhibitory Concentration 50% (MIC50 values), which indic

28 nternalization), high affinity (half-maximal inhibitory concentration, 6.4-12.7 nM), and significant

29 variants of the CXCR4 receptor (half-maximal inhibitory concentration, 8 nM [human]/2 nM [murine]) an

30 a novel high-affinity radioligand (human 50% inhibitory concentration = 9.6 nM) for the PAM site of m

31 bidity detection accuracy of 98.21%, minimum-inhibitory-concentration accuracy of 95.12%, and a drug-

32 ncentrations 100-fold lower than the minimal inhibitory concentration against bacteria.

33 that exhibited a marked increase in the 50% inhibitory concentrations against all tested NAIs (827-,

34 These inhibitors show potent minimum inhibitory concentrations against fluoroquinolone resist

35 P disruption corresponded with lower minimum inhibitory concentrations against the Gram-positive Stap

36 ions for various dosing regimens and minimal inhibitory concentration and calculated the probability

37 In the minimum inhibitory concentration and minimum bactericidal concen

38 concentrations above their protein-adjusted inhibitory concentration and retained their physical and

39 istant mutants increase the in vitro minimum inhibitory concentration and the in vivo 99% effective d

40 ding and increased both the in vitro minimum inhibitory concentration and the in vivo effective dose

41 (coarse and nano) was tested by the minimum inhibitory concentration and time kill assay.

42 bit heritable multidrug increases in minimal inhibitory concentrations and decreases in drug-dependen

43 The minimum inhibitory concentrations and minimum fungicidal concent

44 ibitory concentration (>= % fT > 4 x minimum inhibitory concentration); and 3) were always above the

45 trahigh neutralization potency (half-maximal inhibitory concentration as low as 0.058 ng/ml) and may

46 ill be used, along with the existing minimum inhibitory concentration, as a standard for the in vitro

47 chieve day 2 area under the curve to minimum inhibitory concentration (AUC/MIC) thresholds previously

48 rea under the curve over 24 hours to minimum inhibitory concentration (AUC/MIC).

49 er the concentration time curve over minimal inhibitory concentration (AUC24/MIC) ratios, and emergen

50 er the concentration time curve over minimal inhibitory concentration (AUC24/MIC) ratios, and emergen

51 ssociated with elevated azithromycin minimum inhibitory concentration (AZIem), characterized by a mos

52 t fecal concentrations greater than parasite inhibitory concentrations correlate best with effective

53 odels confirmed that a high triazole minimal inhibitory concentration corresponded with triazole trea

54 While most variation in minimum inhibitory concentrations could be explained by identifi

55 Microbial inhibitory concentration demonstrated platinum and gold

56 Minimum inhibitory concentration distributions of the resistance

57 e 'elite' activity with 50 and 99% effective inhibitory concentrations (EC(50) and EC(99)) of less th

58 Mean half maximal inhibitory concentrations (EC50) for calcium, magnesium

59 of Na(v)1.5 (874 and 231 umol/L half-maximal inhibitory concentration, fast and late sodium current).

60 Fractional Inhibitory Concentration (FIC) studies demonstrated that

61 oncentrations above the protein-adjusted 90% inhibitory concentration for 25 weeks with substantial t

62 t one trough value was above the 90% maximal inhibitory concentration for dolutegravir and HIV viral

63 ation spent over 64 mg/L (4-fold the minimal inhibitory concentration for Pseudomonas aeruginosa) wer

64 ease of >3 doubling dilutions in the minimum inhibitory concentration for third-generation cephalospo

65 ble EVG concentrations that exceeded the 50% inhibitory concentration for wild-type HIV, suggesting t

66 SF was >0.51 ng/mL (proposed CSF 50% maximal inhibitory concentration for wild-type virus) in all sub

67 l derived from the clay exceeded the minimum inhibitory concentrations for E. coli under acidic condi

68 ng susceptibility tests to determine minimum inhibitory concentrations for M. genitalium.

69 Minimum inhibitory concentrations for the lead compounds ranged

70 t drug concentrations inside caseum and high inhibitory concentrations for this bacterial subpopulati

71 hibitory concentration (>= 100% fT > minimum inhibitory concentration) for the first 72 hours of anti

72 istin susceptibility by reducing the minimum inhibitory concentration from 8 to 0.5 mug/ml, 4-fold be

73 ositive predictive value compared to minimum inhibitory concentrations generated by commercial method

74 igecycline therapy given tigecycline minimum inhibitory concentration greater than 2 mg/L compared wi

75 Isolates with ceftriaxone minimum inhibitory concentrations >/=2 microg/mL underwent ESBL

76 demonstrated ceftolozane-tazobactam minimum inhibitory concentrations >/=8 mug/mL.

77 ation); 2) were above four times the minimum inhibitory concentration (>= % fT > 4 x minimum inhibito

78 ation); and 3) were always above the minimum inhibitory concentration (>= 100% fT > minimum inhibitor

79 1) were above the target organism's minimum inhibitory concentration (>= fT > 1 x minimum inhibitory

80 e arms showed improved potency (half-maximal inhibitory concentration (IC(50)) <1 muM) and selectivit

81 showed a 60-fold lower shifted-half-maximal inhibitory concentration (IC(50)) for CYP4Z1 compared to

82 d diflunisal derivatives showed half-maximal inhibitory concentration (IC(50)) values 1 order of magn

83 CoV-2 infection of Vero E6 cells with median inhibitory concentration (IC(50)) values between 24 pico

84 e most potent bNAbs have median half-maximal inhibitory concentration (IC(50)) values in the nanomola

85 n antiproliferative agent, with half-maximal inhibitory concentration (IC(50)) values in the single-

86 egions isolated during VF displayed high 50% inhibitory concentration (IC(50)) values relative to tho

87 agnitude increase in imatinib's half-maximal inhibitory concentration (IC(50)).

88 or estimating the potency [e.g. half-maximum inhibitory concentration (IC) known as IC50] of anti-can

89 RBD neutralized the virus with half-maximal inhibitory concentrations (IC(50) values) as low as 2 ng

90 inhibitors with sub-micromolar half-maximal inhibitory concentrations (IC(50)) in a LOX enzyme activ

91 erative activity in Hep3B cells, with median inhibitory concentrations (IC(50)) of 0.5 ug/mL, 7.49 ug

92 Their DPP-IV half maximal inhibitory concentrations (IC(50)) ranged from 0.55 +/-

93 d five human cancer cells, with half maximal inhibitory concentrations (IC(50)s) of 13.2~37.3 muM.

94 Compared with FAPI-04 (half maximal inhibitory concentration [IC(50)] = 32 nM), the glycocon

95 ility in serum), PSMA affinity (half-maximal inhibitory concentration [IC(50)] range 19.2 +/- 5.8-175

96 se is inhibited by sulfide with half-maximal inhibitory concentration IC50 = 1.1 +/- 0.1 muM, under i

97 ent genotypes, and showed differences in 50% inhibitory concentration (IC50 ) correlating with clinic

98 the best bNAbs (geometric mean half-maximum inhibitory concentration (IC50) < 0.05 mug ml(-1)).

99 P with TDF, but 9.6-fold higher than the 50% inhibitory concentration (IC50) (11.5 ng/mL).

100 viral entry process with a submicromolar 50% inhibitory concentration (IC50) (IC50 = 0.61 +/- 0.23 mu

101 At a 50% inhibitory concentration (IC50) cutoff of 1 mug/ml per a

102 y (ORAC) assays with a measured half-maximal inhibitory concentration (IC50) for the best case of 1.5

103 1 pseudotyped viruses tested with a mean 50% inhibitory concentration (IC50) of 0.002 mug/mL.

104 eutralizing 97% of viruses with a median 50% inhibitory concentration (IC50) of 0.055 mug/ml.

105 Half maximal inhibitory concentration (IC50) of BA were calculated as

106 The DPP-IV half maximal inhibitory concentration (IC50) of H4, a potent sample,

107 an and rat P2X7R orthologs, the half maximal inhibitory concentration (IC50) of JNJ-54173717 was 4.2

108 h isoeugenol showing the lowest half-maximal inhibitory concentration (IC50) values of mycelium growt

109 re determined for 28 drugs with half-maximal inhibitory concentration (IC50) values ranging from 1.03

110 on of 11, all complexes exhibited 50% growth inhibitory concentration (IC50) values that were less th

111 of kelch13 mutations, higher piperaquine 50% inhibitory concentration (IC50) values, and lower mefloq

112 issociation constant (K(d)) and half maximal inhibitory concentration (IC50) values.

113 ing antioxidant activities, the half maximal inhibitory concentration (IC50) was 215.86 mug/ml and Tr

114 avirin increased the error rate, and the 50% inhibitory concentration (IC50) was 27 muM.

115 highest increase in oseltamivir half-maximal inhibitory concentration (IC50), and E119D conferred the

116 h mitochondrial O2 consumption [half maximal inhibitory concentration (IC50): 3.8muM] and ATP synthes

117 des, LPVP and MPVQA, had DPP-IV half maximal inhibitory concentrations (IC50) of 87.0+/-3.2 and 93.3+

118 ld higher IFNbeta (P < 0.00001) half-maximal inhibitory concentrations (IC50) than did donor isolates

119 Half-maximal inhibitory concentrations (IC50) were obtained for each

120 ular isomer, with low nanomolar half-maximal inhibitory concentrations (IC50).

121 ajority of circulating strains in vitro (50% inhibitory concentration [IC50] > 5 mug/ml).

122 rains of Plasmodium falciparum (half maximal inhibitory concentration [IC50] = 1-2 uM), suggesting th

123 azyl (DPPH) radical quenching potential (50% inhibitory concentration, IC50 approximately 0.59mg/mL)

124 authentic SARS-CoV-2 virus with half-maximal inhibitory concentrations (IC50s) in the 10- to 100-ng/m

125 anti-Plasmodium properties with half-maximal inhibitory concentrations (IC50s) of 2.9 +/- 2.4, 10.7 +

126 The 50% inhibitory concentrations (IC50s) were determined.

127 iations (CNVs) with in-vitro piperaquine 50% inhibitory concentrations (IC50s), and tested whether th

128 mosomes were associated with piperaquine 90% inhibitory concentrations (IC90) in a genome-wide analys

129 ified by a luminometric assay and as minimal inhibitory concentration in the liquid phase.

130 ic and drug-resistant bacteria, with minimal inhibitory concentrations in a sub-micromolar range.

131 after gel application and remained above 95% inhibitory concentrations in rectal fluids at 24 hours.

132 complexes inhibited cell proliferation with inhibitory concentrations in the 0.5-120 muM range.

133 iotic mechanisms of action and resistance at inhibitory concentrations in the lab and in the clinic.

134 NS-ZnNPs at sub-inhibitory concentrations inhibited the biofilm formatio

135 Achieving 100% fT greater than minimum inhibitory concentration is a more stringent benchmark c

136 bility testing, and determination of minimum inhibitory concentration is conventionally performed by

137 ynamic target of fT greater than 1 x minimum inhibitory concentration led to similarly high rates of

138 copies per mL and a BMS-626529 half-maximum inhibitory concentration lower than 100 nmol/L were rand

139 hereas 221-7 was borreliacidal (half maximal inhibitory concentration, < 1 nM) against B. burgdorferi

140 ing recombinantly expressed enzymes, minimum inhibitory concentration measurements, steady-state enzy

141 istance, which is measured using the minimum inhibitory concentration metric, tolerance and persisten

142 ates, there were 10 with ceftriaxone minimum inhibitory concentration (MIC) >/=0.06 mg/L and azithrom

143 nd 11.8% (group B) of patients had a minimum inhibitory concentration (MIC) >2 mug/mL to penicillin.

144 ore potent antimicrobial agents [VRE minimum inhibitory concentration (MIC) = 0.01-0.005 mug/mL] with

145 ctive against Staphylococcus aureus [minimum inhibitory concentration (MIC) = 4 ug/mL], while the blu

146 iperacillin/tazobactam and meropenem minimum inhibitory concentration (MIC) and beta-lactam resistanc

147 fungal activity was studied, and the minimal inhibitory concentration (MIC) and minimal fungicidal co

148 vity was determined by measuring the minimum inhibitory concentration (MIC) and minimum bactericidal

149 The minimum inhibitory concentration (MIC) and minimum bactericidal

150 ow classic metrics like the IC50 and minimal inhibitory concentration (MIC) are dubious proxies for u

151 ains were constructed to perform the minimum inhibitory concentration (MIC) assays, which indicated t

152 chmark its performance with standard minimum inhibitory concentration (MIC) assays.

153 tibacterial activities, lowering the minimum inhibitory concentration (MIC) by more than one order of

154 istance but genotypic DST (gDST) and minimum inhibitory concentration (MIC) could be beneficial.

155 nfected by fungi at levels above the minimum inhibitory concentration (MIC) for many fungi.

156 resulted in a 2-fold increase in the minimal inhibitory concentration (MIC) for the hybrid, while mox

157 rs enable accurate prediction of the minimum inhibitory concentration (MIC) in 60 min (p < 0.03).

158 vations that the traditional test of minimum inhibitory concentration (MIC) is not informative enough

159 zithromycin resistance affecting the Minimal Inhibitory Concentration (MIC) levels of 91.2% isolates

160 ected by laboratory estimates of the minimum inhibitory concentration (MIC) needed to prevent bacteri

161 Compound 1f was most potent with a minimal inhibitory concentration (MIC) of 12.5 mug/mL and an Mtb

162 n in dose-time dependent manner with minimum inhibitory concentration (MIC) of 125 mM.

163 osis; the most potent compound had a minimum inhibitory concentration (MIC) of 52 nM and was not cyto

164 The minimum inhibitory concentration (MIC) of an antimicrobial drug

165 Culture assays showed that the minimum inhibitory concentration (MIC) of RSM-932A and MN58b for

166 oncentrations of LL-37 increased the minimum inhibitory concentration (MIC) of S. aureus towards vanc

167 The minimum inhibitory concentration (MIC) of the peptide ranged fro

168 fficacy was linked to the AUC0-24 to minimum inhibitory concentration (MIC) ratio (r(2) = 0.98).

169 Minimum inhibitory concentration (MIC) testing, unlike routine d

170 cin (VAN) area under the curve (AUC)/minimum inhibitory concentration (MIC) to ensure clinical effica

171 Staphylococcus aureus (MRSA), with a minimum inhibitory concentration (MIC) value as low as 0.5 mug/m

172 ested fungal strains, with excellent minimum inhibitory concentration (MIC) values against non-albica

173 tivity of these dihydropyridomycins (minimum inhibitory concentration (MIC) values around 2.5 muM), w

174 The minimum inhibitory concentration (MIC) values generated from our

175 ycobacterium tuberculosis H37Rv with minimum inhibitory concentration (MIC) values of 9.65 and 22.28

176 This covers the minimum inhibitory concentration (MIC) values of the most common

177 d very potent activities [sub-mug/mL minimum inhibitory concentration (MIC) values] against Gram-posi

178 The daptomycin minimum inhibitory concentration (MIC) was 4 mg/L in 78 (69.6%)

179 The minimum inhibitory concentration (MIC) was much lower for Gram p

180 pared its spectrum of inhibition and minimum inhibitory concentration (MIC) with that of nisin A and

181 igma correlates not with a peptide's minimum inhibitory concentration (MIC), but rather its ability t

182 ia to a given drug and establish its minimum inhibitory concentration (MIC).

183 on between exposure and azithromycin minimum inhibitory concentration (MIC).

184 in at a lower concentration than the minimum inhibitory concentration (MIC).

185 on between exposure and azithromycin minimum inhibitory concentration (MIC).

186 icrodilution method to determine the minimum inhibitory concentration (MIC).

187 one-eighth of the resistant strain's minimum inhibitory concentration (MIC).

188 n (Cmax), and standard antimicrobial minimal inhibitory concentrations (MIC) by agar dilution.

189 Leg1/Leg2 showed minimum inhibitory concentrations (MIC) down to 15.6 umol/L and

190 sed on 735 literature data points of minimum inhibitory concentrations (MIC) of Plantae, Bacteria, an

191 Evaluation of the minimal inhibitory concentrations (MIC) quantified the potency o

192 Micelle/dropletsize, and minimal inhibitory concentrations (MIC) were determined.

193 of two circular micropumps, and the minimum inhibitory concentrations (MIC) were then determined via

194 strains as minimal bactericidal and minimal inhibitory concentrations (MIC), are independent of bact

195 lity breakpoint for enterococci (ie, minimum inhibitory concentration [MIC] <=4 mg/L) is appropriate.

196 rofloxacin concentrations (i.e., 50x minimum inhibitory concentration, MIC), despite the lack of obse

197 s were more likely to have meropenem minimum inhibitory concentrations (MICs) >/=16 microg/mL, while

198 l demonstrated elevated azithromycin minimum inhibitory concentrations (MICs) >256 mug/mL and elevate

199 B1 showed potent minimum inhibitory concentrations (MICs) against canine S. pseud

200 ever, we additionally found that the minimum inhibitory concentrations (MICs) against fluoroquinolone

201 in, and ciprofloxacin geometric mean minimum inhibitory concentrations (MICs) as the outcome variable

202 n (Cmax), and standard antimicrobial minimum inhibitory concentrations (MICs) by agar dilution.

203 protein production when determining minimum inhibitory concentrations (MICs) especially by broth dil

204 Minimum inhibitory concentrations (MICs) for ampicillin and amox

205 Minimum inhibitory concentrations (MICs) for ampicillin and amox

206 Minimum inhibitory concentrations (MICs) from some contemporary

207 -kill kinetic assay was performed at minimum inhibitory concentrations (MICs) in all planktonic strai

208 When compared to minimal-inhibitory concentrations (MICs) in laboratory media, AZ

209 t E. faecium strains with daptomycin minimum inhibitory concentrations (MICs) in the higher end of su

210 RUSD can measure minimum inhibitory concentrations (MICs) of commonly used antibi

211 The minimal inhibitory concentrations (MICs) of four antimicrobial a

212 ns nontoxic to mammalian cells), the minimum inhibitory concentrations (MICs) of imipenem against cli

213 ured Neisseria species, and measured minimum inhibitory concentrations (MICs) to ciprofloxacin, cefix

214 Minimum inhibitory concentrations (MICs) were determined on base

215 torvastatin, and simvastatin and the minimum inhibitory concentrations (MICs) were determined.

216 ma drug concentrations and bacterial minimum inhibitory concentrations (MICs) were used to determine

217 s isolates with different antibiotic minimum inhibitory concentrations (MICs).

218 Box and validated 14 hits (defined as a 50% inhibitory concentration of <1 muM).

219 vitro with remarkable potency (half-maximal inhibitory concentration of <2 ng/ml).

220 -only interpretive breakpoint at the minimum inhibitory concentration of <=1 ug/mL.

221 The half maximal inhibitory concentration of (18)F-GP1 to GPIIb/IIIa was

222 ity to S. malaysiensis and exhibited minimum inhibitory concentration of 0.024 ug/mL against methicil

223 A minimum inhibitory concentration of 0.62 ng/mL and minimum paras

224 dies manifest that BM30 (with a half-maximal inhibitory concentration of 0.89 +/- 0.10 muM) is a comp

225 xchange mediated by mouse pendrin with a 50% inhibitory concentration of 1-3 microM, without affectin

226 ies against mTOR and HDAC1 with half-maximal inhibitory concentration of 1.2 and 0.19 nM, respectivel

227 ith a KD of 76 nM against BioA and a minimum inhibitory concentration of 1.7 muM (0.6 mug/mL) against

228 teria monocytogenes: cIsf pool had a minimum inhibitory concentration of 10microg/ml prenylated compo

229 mAb WNV-86 neutralized WNV with a 50% inhibitory concentration of 2 ng ml(-1), one of the most

230 Interestingly, however, the minimum inhibitory concentration of 2B8 against M. tuberculosis

231 IRDye 800CW binds GLP-1R with a half-maximal inhibitory concentration of 3.96 nM.

232 ocyst development in the mosquito with a 50% inhibitory concentration of 30 nM (range: 23-39).

233 or blebbistatin, resulting in a half-maximal inhibitory concentration of 36.3 +/- 4.1 microM.

234 this blocking agent revealed a half maximal inhibitory concentration of 40 nM which is comparable to

235 ilis, and Klebsiella pneumoniae at a minimal inhibitory concentration of 5.0microgmL(-1).

236 The inhibitory concentration of 50% (IC50) values were deter

237 Ga-HZ220 had a lower affinity for GRPr (inhibitory concentration of 50% [IC50], 21.4 +/- 7.4 nM)

238 affinity for the GLP-1R, with a half-maximal inhibitory concentration of 6.3 nM.

239 pharmacodynamic modeling estimated a minimum inhibitory concentration of 83 ng/mL and a minimal paras

240 ity against HIV-1(HXB2), with a half maximal inhibitory concentration of 89 nM.

241 18 h incubation time and reduced the minimal inhibitory concentration of amphotericin B or fluconazol

242 Normally, the minimum inhibitory concentration of an antibiotic, the dosage at

243 uced cell proliferation and reduced the IC50 inhibitory concentration of chemotherapeutic drugs in vi

244 The 50% inhibitory concentration of compound 6 for MAO-B was 227

245 The median minimum inhibitory concentration of DSM265 in blood was estimate

246 the compounds binds PSMA with a half-maximal inhibitory concentration of no more than 10 nM.

247 evaluate the cytopathic effect, the minimum inhibitory concentration of ten antimicrobial agents, th

248 tion ability is measured as the half maximal inhibitory concentration of the antibody (IC50).

249 Minimum inhibitory concentration of voriconazole and natamycin i

250 pathogenic Aspergillus spp. revealed minimal inhibitory concentrations of </=0.06 microg/mL-greater p

251 exhibited very high potency, with 50% virus-inhibitory concentrations of 0.7 to 9 ng ml(-1).

252 Antimicrobial evaluation yielded inhibitory concentrations of 16-64 and 158-316 ug/mL, an

253 d for killing bacteria with colistin minimum inhibitory concentrations of 2 mug/mL.

254 FR-alpha-positive KB cells gave half-maximal inhibitory concentrations of 27.1 +/- 3.7 and 23.8 +/- 4

255 0 epistatic pairs that influence the minimum inhibitory concentrations of 5 different antibiotics in

256 A enzyme preparations were used to determine inhibitory concentrations of 50%.

257 cterial susceptibility testing shows minimum inhibitory concentrations of 80 mg/mL against a model Es

258 the tested pathogenic bacteria with minimum inhibitory concentrations of 8~32 ug/mL, while compound

259 of antibiotic resistance is exposure to sub-inhibitory concentrations of antibiotics.

260 coli, which we use to test the effect of sub-inhibitory concentrations of common antibiotics on the e

261 However, the inhibitory concentrations of NADH in these assays are fa

262 Half-maximal inhibitory concentrations of native HNPs toward ADAMTS13

263 RT) factor 2 (HRT2) peaked concurrently with inhibitory concentrations of Notch1.

264 The minimum inhibitory concentrations of P-A1 and P-A2 were the same

265 , marcAST can accurately measure the minimum inhibitory concentrations of reference bacterial strains

266 Minimum inhibitory concentrations of relevant antibiotics using

267 P. aeruginosa in macrophages exposed to sub-inhibitory concentrations of the fluoroquinolone antibio

268 The minimum inhibitory concentrations of these compounds reached 0.0

269 Inhibitory concentrations of thymol (4.53-22.2 ppm) were

270 -phase and increased colony formation at sub-inhibitory concentrations of vancomycin.

271 Results: The potency (half-maximal inhibitory concentration) of the P2X7 receptor antagonis

272 acillin underdosing when facing high minimal inhibitory concentration pathogens.

273 (131)I-RPS-027, with a 50% inhibitory concentration (PSMA) of 15 nM and a dissociat

274 sistant isolates had alarmingly high minimum inhibitory concentration shifts (16- to >128-fold) compa

275 Polymyxin minimum inhibitory concentrations showed stepwise increases with

276 We perform minimum inhibitory concentration testing for 12 anti-TB drugs to

277 Monthly sputum cultures, minimal inhibitory concentration testing, and adverse event moni

278 time that faropenem persisted above minimum inhibitory concentration (TMIC) on the moxifloxacin-line

279 vels far exceeding the cellular half maximal inhibitory concentration values (>100,000-fold), and apt

280 ted strains of M. tuberculosis, with minimum inhibitory concentration values as low as 0.03 muM (0.01

281 d sensitivity to dasatinib with half maximal inhibitory concentration values below 20 nM was detected

282 ed with significantly higher PI half-maximum inhibitory concentration values compared with other mole

283 Half-maximal inhibitory concentration values for eotaxin-induced chem

284 ase (by 64-128-fold) the tigecycline minimal inhibitory concentration values for Escherichia coli, Kl

285 s, E. coli, and S. typhimurium, with minimum inhibitory concentration values from 14,211 to 3,553 ug.

286 :blood penetration ratios were above the 50% inhibitory concentration values in almost 100% of cases.

287 , four promising candidates emerged with 50% inhibitory concentration values in the 3 to 26 muM range

288 The minimum inhibitory concentration values measured after 24h of an

289 ounds inhibited M(pro), showing half-maximal inhibitory concentration values that ranged from 0.67 to

290 ly (>24-fold to >130-fold differences in 50% inhibitory concentration values).

291 idyl-prolyl isomerase activity (half maximal inhibitory concentration values, 0.2-16.2 mumol/L) and,

292 ng, by preventing mPTP opening (half maximal inhibitory concentration values, 1.4-132 mumol/L) in a c

293 tively correlated (r = -0.52; P =018) to 50% inhibitory concentration values.

294 mong the viruses neutralized, the median 50% inhibitory concentration was 0.001 mug/ml.

295 n method to accurately determine the minimum inhibitory concentration was developed herein.

296 Minimum inhibitory concentrations were higher across antibiotics

297 The half-maximal inhibitory concentrations were independent of the phenot

298 Minimum inhibitory concentrations were interpreted as susceptibl

299 ark compared with T greater than 4 x minimum inhibitory concentration with standard antibiotic dosing

300 ugh to promote tungstate solubility to reach inhibitory concentrations, without precipitation, and co